1. Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy. (October 2020) Authors: Lombardi, A.; Consonni, D.; Carugno, M.; Bozzi, G.; Mangioni, D.; Muscatello, A.; Castelli, V.; Palomba, E.; Cantù, A.P.; Ceriotti, F.; Tiso, B.; Pesatori, A.C.; Riboldi, L.; Bandera, A.; Lunghi, G.; Gori, A. Journal: Clinical microbiology and infection Issue: Volume 26:Number 10(2020) Page Start: 1413.e9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Definition of healthy ranges for alanine aminotransferase levels: a 2020 update. (March 2021) Authors: Valenti, L.; Pelusi, S.; Bianco, C.; Ceriotti, F.; Berzuini, A.; Prat, L. Iogna; Trotti, R.; Baselli, G.; D'Ambrosio, R.; Colombo, M.; Tsochatzis, E.; Fraquelli, M.; Prati, D. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effectiveness, safety and T-cell activation profiles of long-term Myrcludex B treatment in two patients with HDV related compensated cirrhosis. (February 2019) Authors: Loglio, A.; Alexandrov, A.; Renteria, S.C. Uceda; Tham, C.Y.L.; Greco, L.; Borghi, M.; Perbellini, R.; Trombetta, E.; Giovanelli, S.; Porretti, L.; Lecchi, L.; Prati, D.; Ceriotti, F.; Lunghi, G.; Bertoletti, A.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EILF-Italian migrants study: An HCV and HBV micro elimination pilot project. (March 2021) Authors: Colucci, G.; Uceda Renteria, S.; Lunghi, G.; Ceriotti, F.; Sguazzini, E.; Spalenza, S.; Regazzo, C.; Scotti, S.; Renesto, E.; Zucchetti, A.; Paratore, C.; Lampertico, P.; Colombo, M. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Excellent long-term virological and clinical response in HDV compensated cirrhotics treated with high dose Bulevirtide beyond 2.5 years: A case series. (March 2021) Authors: Loglio, A.; Ferenci, P.; Renteria, SC. Uceda; Holzmann, H.; Borghi, M.; Perbellini, R.; Rimondi, A.; Trombetta, E.; Giovanelli, S.; Porretti, L.; Prati, D.; Ceriotti, F.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Improvement of clinical parameters in HDV patients with advanced compensated cirrhosis treated with Bulevirtide monotherapy for 48 weeks. (March 2023) Authors: Degasperi, E.; Anolli, M.P.; Renteria, S.C. Uceda; Sambarino, D.; Borghi, M.; Perbellini, R.; Facchetti, F.; Loglio, A.; Monico, Sara; Fraquelli, M.; Costantino, A.; Ceriotti, F.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Independent determinants and predictors of controlled attenuation parameter (CAP) values in 1, 230 individuals with metabolic dysfunction. (March 2023) Authors: Bianco, C.; Pelusi, S.; Margarita, S.; Malvestiti, F.; Periti, G.; Rondena, J.; Tomasi, M.; Carpani, R.; Vidali, M.; Ceriotti, F.; Prati, D.; Valenti, L. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Omicron SARS-CoV-2 variant outbreak in vaccinated liver transplant (LT) recipients in 2022: A large spread of infection, a mild disease. (March 2023) Authors: Donato, M.F.; Dibenedetto, C.; Farina, E.; Toppetta, A.; Renteria, S.C. Uceda; Rigamonti, C.; Antonelli, B.; Caccamo, L.; Lombardi, A.; Bandera, A.; Ceriotti, F.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PIVKA_II a useful biomarker for hepatocellular carcinoma in caucasian HCV cirrhotic patients treated with direct-acting antivirals. (February 2020) Authors: Degasperi, E.; De Monti, A.; Perbellini, R.; D'Ambrosio, R.; Lunghi, G.; Ceriotti, F.; Perego, A.; Orsini, C.; Borghi, M.; Iavarone, M.; Bruccoleri, M.; Sangiovanni, A.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and efficacy of up to 76 weeks 10 mg/day (high dose) bulevirtide monotherapy in compensated cirrhotics with delta hepatitis. (February 2020) Authors: Loglio, A.; Ferenci, P.; Schlund, F.; Tham, C.Y.L.; van Bömmel, F.; Renteria, SC. Uceda; Borghi, M.; Holzmann, H.; Perbellini, R.; Trombetta, E.; Giovanelli, S.; Porretti, L.; Prati, D.; Ceriotti, F.; Lunghi, G.; Bertoletti, A.; Urban, S.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗